The lack of CK20 immunoreactivity in SVC is helpful in distinguishing these tumors from colorectal adenocarcinoma and urothelial-type bladder carcinoma, usually expressing CK20. The gene discussed is KRT20; the disease is colorectal adenocarcinoma.